ClinicalTrials.gg
Not yet recruitingNCT07900113Updated Oct 28, 2026

The Effect of Health Belief Model-Based HPV Infection and Vaccination Education on University Students' Knowledge and Health Beliefs

An interventional study of Educational intervention HPV in Health Belief Model, Nursing Students and HPV (Human Papillomavirus)-Associated, sponsored by Mersin University. Not yet recruiting. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Mersin University · Not applicable, Interventional, and Other

Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This study aimed to examine changes in knowledge and health beliefs (perceived susceptibility, severity, benefits, and barriers) regarding HPV infection and cervical cancer among students residing in a university dormitory following a planned education program based on the HBM.

RQ1: Do students' HPV knowledge levels differ across pre-education, post-education, and month-three measurements? RQ2: Do students' HPV-related health beliefs (perceived susceptibility, severity, benefits, and barriers) differ across the same time points?

02

Conditions studied

  • Health Belief Model
  • Nursing Students
  • HPV (Human Papillomavirus)-Associated
03

In context

Papillomavirus Infections

576 studies on the registry are indexed under Papillomavirus Infections; 132 are open to participants now.

This study's planned enrollment of 67 is below the median of 235 across 402 interventional studies indexed under Papillomavirus Infections.

Browse Papillomavirus Infections studies →

Lead sponsor

Mersin University is the lead sponsor of 178 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female students who were residing in a dormitory,
  • Had no physical or psychological condition that could impede communication,
  • Were able to read and write Turkish,
  • Volunteered to participate,
  • Provided written

Exclusion criteria

Exclusion Criteria:

  • Students who withdrew from the study at any stage,
  • Did not complete the pre-test or post-test assessments, or
  • Failed to participate in the educational intervention were excluded from the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
67 participants (estimated)

Study arms

  • Experimental
    Education group

    Participants in this arm will receive a structured educational intervention on human papillomavirus (HPV), including information on HPV infection, transmission, prevention, vaccination, screening, and risk factors. Participants' baseline knowledge will be assessed using a pre-test before the intervention. Following completion of the educational intervention, the same or equivalent assessment will be administered as a post-test to evaluate changes in HPV-related knowledge.

    Other: Educational intervention HPV

Interventions

  • OtherEducational intervention HPV

    Educational intervention on human papillomavirus (HPV), including information on HPV infection, transmission, prevention, vaccination, screening, and risk factors.

06

What researchers measure

Primary outcomes

  1. Change in HPV-Related Knowledge Score

    Change in participants' HPV-related knowledge scores from pre-test (baseline) to post-test, assessed using the HPV knowledge questionnaire. Higher scores indicate a higher level of HPV-related knowledge.

    Time frame: Baseline, immediately after the educational intervention, and 3 months after the intervention

  2. Change in Health Beliefs Regarding HPV and HPV Vaccination

    Changes in participants' health beliefs regarding human papillomavirus (HPV) infection and HPV vaccination will be assessed using the Health Belief Model Scale for Human Papillomavirus and its Vaccination (HBMS-HPVV) at baseline, immediately after the educational intervention, and 3 months after the intervention.

    Time frame: Baseline, immediately after the educational intervention, and 3 months after the intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — The dataset may be shared with researchers upon reasonable request after publication of the study.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07900113
Lead sponsor
Mersin University
Responsible party
Aysu Buldum (Research Assistant, PhD, Mersin University) — Principal investigator
First posted
Oct 28, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Aysu Buldum Res. Assist., PhD
Contact
aysukoptur@mersin.edu.tr
+905377147344

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion